Edward Havranek
Concepts (459)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Failure | 50 | 2018 | 1969 | 2.540 |
Why?
| Hypertension | 20 | 2022 | 1203 | 2.410 |
Why?
| Antihypertensive Agents | 9 | 2021 | 437 | 2.080 |
Why?
| Medication Adherence | 10 | 2022 | 556 | 1.860 |
Why?
| Text Messaging | 5 | 2020 | 155 | 1.830 |
Why?
| Healthcare Disparities | 8 | 2023 | 496 | 1.650 |
Why?
| Socioeconomic Factors | 11 | 2021 | 1129 | 1.330 |
Why?
| Heart Diseases | 3 | 2019 | 341 | 1.260 |
Why?
| Social Values | 2 | 2021 | 38 | 1.250 |
Why?
| Racism | 3 | 2021 | 102 | 1.200 |
Why?
| Health Status | 12 | 2018 | 726 | 1.130 |
Why?
| Myocardial Infarction | 17 | 2015 | 968 | 1.040 |
Why?
| Social Determinants of Health | 2 | 2018 | 129 | 1.030 |
Why?
| Weight Loss | 5 | 2018 | 655 | 1.020 |
Why?
| Blood Pressure | 9 | 2016 | 1664 | 1.000 |
Why?
| Hospitalization | 24 | 2020 | 1785 | 0.980 |
Why?
| Cardiovascular Diseases | 11 | 2019 | 1798 | 0.970 |
Why?
| Out-of-Hospital Cardiac Arrest | 3 | 2019 | 79 | 0.960 |
Why?
| Prediabetic State | 2 | 2016 | 234 | 0.910 |
Why?
| Patient Satisfaction | 6 | 2019 | 610 | 0.890 |
Why?
| Health Services Accessibility | 2 | 2019 | 781 | 0.880 |
Why?
| Resuscitation Orders | 2 | 2020 | 40 | 0.850 |
Why?
| Aged | 79 | 2021 | 19657 | 0.850 |
Why?
| Hypertrophy, Left Ventricular | 3 | 2008 | 107 | 0.840 |
Why?
| Attitude to Health | 2 | 2021 | 410 | 0.840 |
Why?
| Sexual Health | 2 | 2020 | 46 | 0.830 |
Why?
| Humans | 141 | 2023 | 118972 | 0.800 |
Why?
| Middle Aged | 60 | 2022 | 27617 | 0.790 |
Why?
| Physician-Patient Relations | 5 | 2013 | 490 | 0.780 |
Why?
| Sexually Transmitted Diseases | 2 | 2020 | 155 | 0.770 |
Why?
| Health Status Disparities | 3 | 2021 | 209 | 0.770 |
Why?
| Male | 99 | 2022 | 57801 | 0.750 |
Why?
| Depression | 8 | 2018 | 1132 | 0.750 |
Why?
| Female | 102 | 2022 | 61564 | 0.740 |
Why?
| Residence Characteristics | 3 | 2021 | 299 | 0.700 |
Why?
| Cardiac Output, Low | 5 | 2006 | 68 | 0.690 |
Why?
| Primary Health Care | 4 | 2019 | 1560 | 0.680 |
Why?
| Atherosclerosis | 2 | 2019 | 345 | 0.660 |
Why?
| Diabetes Mellitus | 9 | 2018 | 942 | 0.640 |
Why?
| Colorado | 22 | 2021 | 4196 | 0.640 |
Why?
| Choice Behavior | 1 | 2019 | 160 | 0.630 |
Why?
| United States | 44 | 2023 | 12555 | 0.630 |
Why?
| Minority Groups | 3 | 2023 | 237 | 0.600 |
Why?
| Heart Arrest | 2 | 2020 | 291 | 0.570 |
Why?
| Communication | 4 | 2023 | 761 | 0.560 |
Why?
| American Heart Association | 3 | 2018 | 270 | 0.540 |
Why?
| Safety-net Providers | 2 | 2018 | 96 | 0.540 |
Why?
| Emergency Service, Hospital | 5 | 2021 | 1864 | 0.520 |
Why?
| Health Services Research | 2 | 2015 | 385 | 0.490 |
Why?
| Delivery of Health Care | 7 | 2023 | 867 | 0.470 |
Why?
| Emergency Medical Services | 4 | 2023 | 589 | 0.470 |
Why?
| Risk Factors | 26 | 2019 | 9000 | 0.460 |
Why?
| Aged, 80 and over | 29 | 2021 | 6561 | 0.450 |
Why?
| Blood Pressure Determination | 1 | 2014 | 133 | 0.450 |
Why?
| Patient Acceptance of Health Care | 1 | 2018 | 687 | 0.440 |
Why?
| Medically Uninsured | 1 | 2013 | 125 | 0.420 |
Why?
| Adult | 30 | 2023 | 31512 | 0.420 |
Why?
| Guideline Adherence | 6 | 2021 | 523 | 0.420 |
Why?
| Decision Making | 2 | 2016 | 809 | 0.410 |
Why?
| Surveys and Questionnaires | 10 | 2018 | 4708 | 0.410 |
Why?
| Patient-Centered Care | 2 | 2016 | 497 | 0.400 |
Why?
| Blood Pressure Monitoring, Ambulatory | 2 | 2011 | 66 | 0.400 |
Why?
| Decision Support Techniques | 1 | 2015 | 364 | 0.400 |
Why?
| Physicians, Primary Care | 2 | 2018 | 222 | 0.390 |
Why?
| Carotid Artery Diseases | 1 | 2011 | 58 | 0.390 |
Why?
| Insurance, Health | 1 | 2013 | 244 | 0.380 |
Why?
| Cohort Studies | 26 | 2020 | 5116 | 0.380 |
Why?
| Follow-Up Studies | 17 | 2022 | 4596 | 0.380 |
Why?
| Ventricular Dysfunction, Left | 6 | 2008 | 374 | 0.380 |
Why?
| Survival Analysis | 7 | 2010 | 1267 | 0.380 |
Why?
| Electrocardiography | 4 | 2009 | 556 | 0.380 |
Why?
| Kidney Diseases | 3 | 2011 | 439 | 0.380 |
Why?
| Risk Assessment | 10 | 2019 | 3057 | 0.380 |
Why?
| Practice Patterns, Physicians' | 3 | 2018 | 1200 | 0.370 |
Why?
| Coronary Artery Disease | 3 | 2013 | 647 | 0.370 |
Why?
| Quality of Life | 12 | 2019 | 2366 | 0.340 |
Why?
| Survival Rate | 13 | 2020 | 1720 | 0.340 |
Why?
| Quality of Health Care | 7 | 2007 | 586 | 0.330 |
Why?
| Exercise | 2 | 2018 | 1657 | 0.330 |
Why?
| Attitude to Death | 1 | 2008 | 61 | 0.320 |
Why?
| Cardiopulmonary Resuscitation | 3 | 2020 | 225 | 0.320 |
Why?
| Renin-Angiotensin System | 1 | 2008 | 82 | 0.310 |
Why?
| Proportional Hazards Models | 11 | 2015 | 1125 | 0.310 |
Why?
| Heart Rate | 2 | 2011 | 729 | 0.310 |
Why?
| Medicare | 14 | 2017 | 663 | 0.310 |
Why?
| Atrial Fibrillation | 2 | 2009 | 338 | 0.300 |
Why?
| Patient Education as Topic | 4 | 2018 | 699 | 0.300 |
Why?
| Angiotensin-Converting Enzyme Inhibitors | 8 | 2008 | 195 | 0.300 |
Why?
| Retrospective Studies | 30 | 2020 | 12978 | 0.290 |
Why?
| Sex Factors | 10 | 2020 | 1781 | 0.280 |
Why?
| Stroke | 3 | 2021 | 1047 | 0.280 |
Why?
| Diabetic Angiopathies | 4 | 2009 | 260 | 0.280 |
Why?
| Models, Statistical | 2 | 2013 | 636 | 0.280 |
Why?
| Kidney | 3 | 2011 | 1353 | 0.270 |
Why?
| Cross-Sectional Studies | 14 | 2017 | 4552 | 0.270 |
Why?
| Prevalence | 7 | 2018 | 2326 | 0.270 |
Why?
| Value of Life | 1 | 2005 | 19 | 0.260 |
Why?
| Insurance, Health, Reimbursement | 2 | 2017 | 88 | 0.250 |
Why?
| Young Adult | 9 | 2021 | 10793 | 0.250 |
Why?
| Palliative Care | 4 | 2016 | 629 | 0.250 |
Why?
| Multivariate Analysis | 10 | 2017 | 1474 | 0.250 |
Why?
| Ambulances | 2 | 2023 | 49 | 0.250 |
Why?
| Monitoring, Ambulatory | 1 | 2005 | 84 | 0.250 |
Why?
| Patient Compliance | 4 | 2018 | 537 | 0.240 |
Why?
| Prognosis | 9 | 2018 | 3443 | 0.240 |
Why?
| Peer Review, Research | 1 | 2004 | 35 | 0.240 |
Why?
| Epidemiologic Studies | 1 | 2004 | 58 | 0.240 |
Why?
| Nisoldipine | 1 | 2003 | 6 | 0.230 |
Why?
| Enalapril | 1 | 2003 | 18 | 0.230 |
Why?
| Single-Blind Method | 2 | 2021 | 269 | 0.230 |
Why?
| Smoking Cessation | 1 | 2007 | 360 | 0.230 |
Why?
| Attitude of Health Personnel | 2 | 2012 | 992 | 0.230 |
Why?
| Shock, Traumatic | 1 | 2023 | 18 | 0.230 |
Why?
| Treatment Outcome | 15 | 2023 | 9342 | 0.230 |
Why?
| Hypoglycemic Agents | 5 | 2012 | 1032 | 0.230 |
Why?
| Pneumonia | 2 | 2019 | 592 | 0.220 |
Why?
| Social Class | 2 | 2019 | 218 | 0.220 |
Why?
| Sepsis | 2 | 2019 | 531 | 0.220 |
Why?
| Sexual Behavior | 3 | 2020 | 437 | 0.220 |
Why?
| Critical Illness | 2 | 2023 | 662 | 0.210 |
Why?
| Prospective Studies | 12 | 2019 | 6471 | 0.210 |
Why?
| Mexican Americans | 2 | 2015 | 100 | 0.210 |
Why?
| Delivery of Health Care, Integrated | 1 | 2005 | 233 | 0.210 |
Why?
| Communication Barriers | 1 | 2023 | 94 | 0.210 |
Why?
| Intention to Treat Analysis | 1 | 2021 | 70 | 0.210 |
Why?
| Perception | 1 | 2004 | 314 | 0.210 |
Why?
| Diabetes Mellitus, Type 2 | 4 | 2017 | 2174 | 0.200 |
Why?
| Telemedicine | 2 | 2011 | 664 | 0.200 |
Why?
| Electronic Health Records | 2 | 2018 | 829 | 0.200 |
Why?
| Acculturation | 2 | 2012 | 51 | 0.200 |
Why?
| Glomerular Filtration Rate | 5 | 2011 | 683 | 0.200 |
Why?
| Stroke Volume | 7 | 2008 | 512 | 0.200 |
Why?
| Cardiologists | 2 | 2018 | 40 | 0.190 |
Why?
| Drug Prescriptions | 6 | 2009 | 248 | 0.190 |
Why?
| Writing | 1 | 2021 | 88 | 0.190 |
Why?
| Adolescent | 10 | 2020 | 18480 | 0.190 |
Why?
| Brain Ischemia | 2 | 2021 | 310 | 0.190 |
Why?
| Professional-Patient Relations | 1 | 2021 | 147 | 0.190 |
Why?
| Incidence | 6 | 2021 | 2424 | 0.180 |
Why?
| Age Factors | 11 | 2018 | 2995 | 0.180 |
Why?
| Chronic Disease | 6 | 2018 | 1636 | 0.180 |
Why?
| Chi-Square Distribution | 5 | 2015 | 525 | 0.180 |
Why?
| Cardiology | 3 | 2007 | 272 | 0.170 |
Why?
| Fluid Therapy | 1 | 2020 | 130 | 0.170 |
Why?
| Health Care Surveys | 4 | 2019 | 546 | 0.170 |
Why?
| Quality Assurance, Health Care | 6 | 2007 | 325 | 0.170 |
Why?
| Qualitative Research | 3 | 2019 | 953 | 0.170 |
Why?
| Time Factors | 10 | 2015 | 6412 | 0.170 |
Why?
| Income | 1 | 2019 | 173 | 0.170 |
Why?
| Public Opinion | 1 | 2019 | 59 | 0.170 |
Why?
| Shock | 1 | 2020 | 91 | 0.170 |
Why?
| Formative Feedback | 1 | 2018 | 22 | 0.160 |
Why?
| Patient Care Team | 2 | 2018 | 521 | 0.160 |
Why?
| Emergency Treatment | 1 | 2019 | 110 | 0.160 |
Why?
| Medical Audit | 1 | 2018 | 75 | 0.160 |
Why?
| Patient Selection | 5 | 2009 | 676 | 0.160 |
Why?
| Withholding Treatment | 2 | 2016 | 67 | 0.160 |
Why?
| Censuses | 1 | 2017 | 19 | 0.160 |
Why?
| Contraception | 1 | 2019 | 118 | 0.160 |
Why?
| Multilevel Analysis | 1 | 2017 | 25 | 0.160 |
Why?
| Severity of Illness Index | 3 | 2019 | 2674 | 0.160 |
Why?
| Health Literacy | 2 | 2018 | 169 | 0.160 |
Why?
| Patient Readmission | 5 | 2012 | 634 | 0.160 |
Why?
| California | 1 | 2019 | 382 | 0.160 |
Why?
| Angina Pectoris | 2 | 2008 | 63 | 0.160 |
Why?
| Patient Navigation | 1 | 2019 | 77 | 0.150 |
Why?
| Odds Ratio | 6 | 2018 | 996 | 0.150 |
Why?
| Peer Group | 1 | 2019 | 207 | 0.150 |
Why?
| International Cooperation | 1 | 2018 | 177 | 0.150 |
Why?
| Interviews as Topic | 3 | 2015 | 599 | 0.150 |
Why?
| Goals | 1 | 2018 | 167 | 0.150 |
Why?
| Hyperglycemia | 3 | 2010 | 312 | 0.150 |
Why?
| ST Elevation Myocardial Infarction | 1 | 2017 | 51 | 0.150 |
Why?
| Comorbidity | 9 | 2012 | 1527 | 0.150 |
Why?
| Statistics as Topic | 3 | 2008 | 307 | 0.150 |
Why?
| Logistic Models | 9 | 2017 | 1901 | 0.140 |
Why?
| Program Development | 1 | 2018 | 357 | 0.140 |
Why?
| Leadership | 2 | 2018 | 311 | 0.140 |
Why?
| Self-Management | 1 | 2018 | 136 | 0.140 |
Why?
| Weight Reduction Programs | 1 | 2017 | 93 | 0.140 |
Why?
| Carotid Intima-Media Thickness | 1 | 2016 | 68 | 0.140 |
Why?
| Health Knowledge, Attitudes, Practice | 2 | 2021 | 1185 | 0.140 |
Why?
| Urban Population | 1 | 2018 | 409 | 0.140 |
Why?
| Hospital Mortality | 5 | 2019 | 814 | 0.140 |
Why?
| Organizational Case Studies | 1 | 2015 | 74 | 0.140 |
Why?
| Diuretics | 3 | 2006 | 76 | 0.140 |
Why?
| Cell Phone | 1 | 2016 | 81 | 0.130 |
Why?
| Registries | 6 | 2020 | 1810 | 0.130 |
Why?
| Predictive Value of Tests | 4 | 2010 | 1868 | 0.130 |
Why?
| Xanthines | 2 | 2007 | 15 | 0.130 |
Why?
| Diffusion of Innovation | 1 | 2015 | 98 | 0.130 |
Why?
| Renal Dialysis | 1 | 2019 | 378 | 0.130 |
Why?
| Clinical Decision-Making | 1 | 2017 | 278 | 0.130 |
Why?
| Hypercholesterolemia | 1 | 2015 | 93 | 0.130 |
Why?
| Thiazolidinediones | 3 | 2005 | 146 | 0.130 |
Why?
| Exercise Test | 1 | 2017 | 551 | 0.130 |
Why?
| Organizational Culture | 1 | 2015 | 121 | 0.130 |
Why?
| Community Health Services | 2 | 2008 | 212 | 0.130 |
Why?
| Education, Medical | 1 | 2018 | 239 | 0.130 |
Why?
| Lipoproteins | 1 | 2015 | 162 | 0.130 |
Why?
| Organizational Innovation | 1 | 2015 | 138 | 0.130 |
Why?
| Cultural Competency | 2 | 2013 | 78 | 0.130 |
Why?
| Fatty Acids, Omega-3 | 1 | 2015 | 125 | 0.120 |
Why?
| Blood Vessels | 1 | 2016 | 187 | 0.120 |
Why?
| Acute Coronary Syndrome | 1 | 2017 | 257 | 0.120 |
Why?
| ROC Curve | 2 | 2020 | 473 | 0.120 |
Why?
| Ventricular Function, Left | 4 | 2009 | 468 | 0.120 |
Why?
| Adiponectin | 1 | 2015 | 226 | 0.120 |
Why?
| Pilot Projects | 3 | 2015 | 1419 | 0.120 |
Why?
| Practice Guidelines as Topic | 4 | 2017 | 1440 | 0.120 |
Why?
| Cholesterol | 1 | 2015 | 373 | 0.120 |
Why?
| Aspirin | 3 | 2005 | 334 | 0.120 |
Why?
| Creatinine | 5 | 2006 | 491 | 0.110 |
Why?
| Kidney Failure, Chronic | 1 | 2019 | 516 | 0.110 |
Why?
| Triglycerides | 1 | 2015 | 519 | 0.110 |
Why?
| Disease Management | 3 | 2008 | 571 | 0.110 |
Why?
| Inpatients | 5 | 2009 | 388 | 0.110 |
Why?
| Metformin | 3 | 2005 | 295 | 0.110 |
Why?
| Randomized Controlled Trials as Topic | 4 | 2005 | 1244 | 0.110 |
Why?
| Diabetes Complications | 3 | 2009 | 218 | 0.110 |
Why?
| Kaplan-Meier Estimate | 2 | 2015 | 842 | 0.100 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2006 | 387 | 0.100 |
Why?
| Hyperlipidemias | 1 | 2012 | 128 | 0.100 |
Why?
| Trust | 1 | 2012 | 113 | 0.100 |
Why?
| Sensitivity and Specificity | 1 | 2016 | 1795 | 0.100 |
Why?
| Hospitals, Military | 1 | 2011 | 34 | 0.100 |
Why?
| Medical Laboratory Science | 1 | 2010 | 7 | 0.100 |
Why?
| Biomedical Research | 2 | 2007 | 612 | 0.100 |
Why?
| Pregnancy | 2 | 2020 | 5690 | 0.100 |
Why?
| Vascular Stiffness | 1 | 2015 | 425 | 0.100 |
Why?
| Adiposity | 1 | 2015 | 516 | 0.100 |
Why?
| Anticholesteremic Agents | 1 | 2012 | 130 | 0.100 |
Why?
| Affect | 1 | 2012 | 240 | 0.090 |
Why?
| Health Promotion | 1 | 2017 | 691 | 0.090 |
Why?
| Adrenergic beta-Antagonists | 3 | 2008 | 301 | 0.090 |
Why?
| Diet | 2 | 2015 | 1153 | 0.090 |
Why?
| Telephone | 1 | 2011 | 152 | 0.090 |
Why?
| Double-Blind Method | 4 | 2015 | 1687 | 0.090 |
Why?
| Body Mass Index | 2 | 2016 | 2092 | 0.090 |
Why?
| Health Status Indicators | 3 | 2008 | 154 | 0.090 |
Why?
| Nutrition Surveys | 2 | 2008 | 233 | 0.090 |
Why?
| Angioplasty, Balloon, Coronary | 1 | 2009 | 148 | 0.080 |
Why?
| Captopril | 1 | 2008 | 12 | 0.080 |
Why?
| Infant, Newborn | 1 | 2019 | 5255 | 0.080 |
Why?
| Obesity | 2 | 2015 | 2746 | 0.080 |
Why?
| Pharmacists | 1 | 2011 | 238 | 0.080 |
Why?
| Valsartan | 1 | 2008 | 22 | 0.080 |
Why?
| Tetrazoles | 1 | 2008 | 32 | 0.080 |
Why?
| Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 32 | 0.080 |
Why?
| Longitudinal Studies | 3 | 2011 | 2513 | 0.080 |
Why?
| Spirituality | 1 | 2009 | 65 | 0.080 |
Why?
| Spironolactone | 2 | 2005 | 34 | 0.080 |
Why?
| Spouse Abuse | 1 | 2008 | 45 | 0.080 |
Why?
| Health Surveys | 1 | 2010 | 454 | 0.080 |
Why?
| Valine | 1 | 2008 | 77 | 0.080 |
Why?
| Adenosine A1 Receptor Antagonists | 1 | 2007 | 2 | 0.080 |
Why?
| Carbazoles | 1 | 2008 | 80 | 0.080 |
Why?
| Propanolamines | 1 | 2008 | 93 | 0.080 |
Why?
| Medical Records Systems, Computerized | 1 | 2008 | 92 | 0.080 |
Why?
| Patients | 1 | 2009 | 175 | 0.080 |
Why?
| Medically Underserved Area | 1 | 2008 | 87 | 0.080 |
Why?
| Linear Models | 4 | 2015 | 827 | 0.080 |
Why?
| United States Department of Veterans Affairs | 1 | 2011 | 555 | 0.080 |
Why?
| Social Workers | 2 | 2018 | 28 | 0.080 |
Why?
| Insulin Resistance | 1 | 2015 | 1180 | 0.080 |
Why?
| Vascular Diseases | 1 | 2009 | 241 | 0.070 |
Why?
| Self Care | 1 | 2009 | 357 | 0.070 |
Why?
| Blood Urea Nitrogen | 1 | 2006 | 59 | 0.070 |
Why?
| Defibrillators, Implantable | 1 | 2010 | 299 | 0.070 |
Why?
| Internal Medicine | 1 | 2008 | 215 | 0.070 |
Why?
| Biomarkers | 6 | 2015 | 3588 | 0.070 |
Why?
| Coronary Artery Bypass | 2 | 2006 | 209 | 0.070 |
Why?
| National Health Programs | 1 | 2005 | 21 | 0.070 |
Why?
| Dyspnea | 2 | 2018 | 201 | 0.070 |
Why?
| Diet, Sodium-Restricted | 1 | 2006 | 34 | 0.070 |
Why?
| Patient Admission | 4 | 2009 | 176 | 0.070 |
Why?
| Body Temperature | 1 | 2006 | 215 | 0.070 |
Why?
| Fatigue | 2 | 2018 | 297 | 0.070 |
Why?
| Cost of Illness | 2 | 2004 | 258 | 0.070 |
Why?
| Self Report | 2 | 2022 | 699 | 0.070 |
Why?
| Patient Reported Outcome Measures | 2 | 2018 | 252 | 0.070 |
Why?
| Edema | 1 | 2006 | 124 | 0.070 |
Why?
| Patient Discharge | 4 | 2006 | 796 | 0.070 |
Why?
| Nurses | 2 | 2018 | 142 | 0.060 |
Why?
| Health Education | 1 | 2008 | 318 | 0.060 |
Why?
| Natriuretic Peptide, Brain | 1 | 2005 | 106 | 0.060 |
Why?
| Interinstitutional Relations | 1 | 2005 | 55 | 0.060 |
Why?
| Asthma | 1 | 2018 | 2158 | 0.060 |
Why?
| Terminally Ill | 1 | 2005 | 33 | 0.060 |
Why?
| Hospital Costs | 1 | 2005 | 110 | 0.060 |
Why?
| Drug Costs | 1 | 2005 | 94 | 0.060 |
Why?
| Specialization | 1 | 2005 | 120 | 0.060 |
Why?
| Cardiac Pacing, Artificial | 1 | 2005 | 85 | 0.060 |
Why?
| Coronary Care Units | 1 | 2004 | 14 | 0.060 |
Why?
| United Kingdom | 1 | 2005 | 236 | 0.060 |
Why?
| Depressive Disorder | 1 | 2007 | 333 | 0.060 |
Why?
| Counseling | 1 | 2007 | 353 | 0.060 |
Why?
| Nurse Practitioners | 1 | 2006 | 107 | 0.060 |
Why?
| Anemia | 1 | 2005 | 146 | 0.060 |
Why?
| Multicenter Studies as Topic | 1 | 2005 | 253 | 0.060 |
Why?
| Alcohol Drinking | 2 | 2009 | 652 | 0.060 |
Why?
| Nurse Administrators | 1 | 2004 | 33 | 0.060 |
Why?
| Medicine | 1 | 2005 | 106 | 0.060 |
Why?
| Cultural Characteristics | 1 | 2004 | 61 | 0.060 |
Why?
| Educational Status | 1 | 2006 | 437 | 0.060 |
Why?
| North America | 1 | 2004 | 266 | 0.060 |
Why?
| Internet | 1 | 2008 | 633 | 0.060 |
Why?
| Ibuprofen | 1 | 2003 | 76 | 0.060 |
Why?
| Albuminuria | 1 | 2004 | 195 | 0.060 |
Why?
| Vulnerable Populations | 1 | 2004 | 147 | 0.060 |
Why?
| Needs Assessment | 1 | 2005 | 327 | 0.060 |
Why?
| Thiazoles | 1 | 2003 | 121 | 0.060 |
Why?
| Calcium Channel Blockers | 1 | 2003 | 117 | 0.060 |
Why?
| South Africa | 1 | 2023 | 163 | 0.060 |
Why?
| Risk Reduction Behavior | 1 | 2004 | 199 | 0.050 |
Why?
| Continuity of Patient Care | 1 | 2005 | 265 | 0.050 |
Why?
| Weight Gain | 1 | 2006 | 493 | 0.050 |
Why?
| Diuresis | 1 | 2002 | 8 | 0.050 |
Why?
| Bayes Theorem | 1 | 2004 | 344 | 0.050 |
Why?
| Purinergic P1 Receptor Antagonists | 1 | 2002 | 7 | 0.050 |
Why?
| Hypertension, Malignant | 1 | 2002 | 2 | 0.050 |
Why?
| Health Behavior | 2 | 2011 | 720 | 0.050 |
Why?
| Furosemide | 1 | 2002 | 35 | 0.050 |
Why?
| Cooperative Behavior | 1 | 2005 | 408 | 0.050 |
Why?
| Ambulatory Care | 2 | 2006 | 482 | 0.050 |
Why?
| Cardiac Tamponade | 1 | 2002 | 16 | 0.050 |
Why?
| Hospice Care | 1 | 2005 | 174 | 0.050 |
Why?
| Pain Measurement | 1 | 2004 | 469 | 0.050 |
Why?
| Total Quality Management | 1 | 2002 | 61 | 0.050 |
Why?
| Lupus Nephritis | 1 | 2002 | 55 | 0.050 |
Why?
| Health Care Costs | 1 | 2004 | 394 | 0.050 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 304 | 0.050 |
Why?
| Health Maintenance Organizations | 2 | 2012 | 96 | 0.050 |
Why?
| Mortality | 2 | 2018 | 299 | 0.050 |
Why?
| Algorithms | 1 | 2008 | 1541 | 0.050 |
Why?
| Veterans | 1 | 2011 | 1208 | 0.050 |
Why?
| Platelet Aggregation Inhibitors | 1 | 2003 | 402 | 0.050 |
Why?
| Contraindications | 3 | 2005 | 86 | 0.050 |
Why?
| Emergencies | 1 | 2021 | 153 | 0.050 |
Why?
| Blood Glucose | 2 | 2009 | 1939 | 0.050 |
Why?
| Confidence Intervals | 2 | 2012 | 324 | 0.040 |
Why?
| Family Practice | 1 | 2004 | 438 | 0.040 |
Why?
| Coronary Disease | 1 | 2002 | 356 | 0.040 |
Why?
| Risk Adjustment | 1 | 2020 | 79 | 0.040 |
Why?
| Length of Stay | 2 | 2017 | 1032 | 0.040 |
Why?
| Sexuality | 1 | 2019 | 18 | 0.040 |
Why?
| Area Under Curve | 1 | 2020 | 296 | 0.040 |
Why?
| Geographic Mapping | 1 | 2018 | 21 | 0.040 |
Why?
| Electric Countershock | 1 | 2019 | 110 | 0.040 |
Why?
| Research | 2 | 2018 | 411 | 0.040 |
Why?
| Hospitals | 1 | 2003 | 598 | 0.040 |
Why?
| Zimbabwe | 1 | 2018 | 39 | 0.040 |
Why?
| Program Evaluation | 2 | 2018 | 845 | 0.040 |
Why?
| Patient Health Questionnaire | 1 | 2018 | 19 | 0.040 |
Why?
| Palliative Medicine | 1 | 2018 | 13 | 0.040 |
Why?
| Alcoholism | 1 | 2004 | 717 | 0.040 |
Why?
| Anxiety | 2 | 2018 | 845 | 0.040 |
Why?
| Cholesterol, LDL | 2 | 2012 | 316 | 0.040 |
Why?
| Capacity Building | 1 | 2018 | 51 | 0.040 |
Why?
| Combined Modality Therapy | 2 | 2011 | 1166 | 0.040 |
Why?
| Time-to-Treatment | 1 | 2018 | 149 | 0.040 |
Why?
| Resuscitation | 1 | 2020 | 252 | 0.040 |
Why?
| Emotional Adjustment | 1 | 2016 | 18 | 0.040 |
Why?
| Peer Review | 2 | 2007 | 40 | 0.040 |
Why?
| Sex Distribution | 1 | 2017 | 351 | 0.040 |
Why?
| Secondary Prevention | 1 | 2018 | 227 | 0.040 |
Why?
| Analysis of Variance | 1 | 2020 | 1293 | 0.040 |
Why?
| Primary Prevention | 1 | 2018 | 185 | 0.040 |
Why?
| Sex Offenses | 1 | 2019 | 148 | 0.030 |
Why?
| Feasibility Studies | 1 | 2019 | 749 | 0.030 |
Why?
| Respiration, Artificial | 1 | 2020 | 545 | 0.030 |
Why?
| Diet Surveys | 1 | 2015 | 85 | 0.030 |
Why?
| Motivation | 1 | 2020 | 506 | 0.030 |
Why?
| Population Surveillance | 1 | 2018 | 413 | 0.030 |
Why?
| Protective Factors | 1 | 2015 | 92 | 0.030 |
Why?
| Insurance Coverage | 1 | 2017 | 208 | 0.030 |
Why?
| Pulse Wave Analysis | 1 | 2016 | 216 | 0.030 |
Why?
| Emergency Medicine | 1 | 2018 | 238 | 0.030 |
Why?
| Canada | 2 | 2006 | 340 | 0.030 |
Why?
| Medical Records | 2 | 2006 | 163 | 0.030 |
Why?
| Healthy Volunteers | 1 | 2015 | 201 | 0.030 |
Why?
| Neoplasms | 1 | 2009 | 2179 | 0.030 |
Why?
| Consensus | 2 | 2007 | 534 | 0.030 |
Why?
| Language | 1 | 2017 | 271 | 0.030 |
Why?
| Mineralocorticoid Receptor Antagonists | 2 | 2005 | 46 | 0.030 |
Why?
| Administration, Oral | 2 | 2007 | 756 | 0.030 |
Why?
| Regression Analysis | 2 | 2009 | 983 | 0.030 |
Why?
| Pain Management | 1 | 2016 | 294 | 0.030 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2002 | 1137 | 0.030 |
Why?
| Stereotyped Behavior | 1 | 2012 | 21 | 0.030 |
Why?
| Aging | 1 | 2003 | 1670 | 0.030 |
Why?
| Quality Indicators, Health Care | 2 | 2006 | 295 | 0.030 |
Why?
| Up-Regulation | 1 | 2015 | 872 | 0.030 |
Why?
| Pain | 1 | 2018 | 735 | 0.030 |
Why?
| Disease Progression | 2 | 2011 | 2490 | 0.030 |
Why?
| Cardiac Resynchronization Therapy | 1 | 2012 | 42 | 0.030 |
Why?
| Culture | 1 | 2012 | 129 | 0.020 |
Why?
| Speech Recognition Software | 1 | 2010 | 11 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 2 | 2007 | 1945 | 0.020 |
Why?
| Cause of Death | 1 | 2012 | 380 | 0.020 |
Why?
| User-Computer Interface | 1 | 2010 | 163 | 0.020 |
Why?
| Urban Health Services | 1 | 2009 | 60 | 0.020 |
Why?
| Medication Therapy Management | 1 | 2010 | 72 | 0.020 |
Why?
| Anti-Bacterial Agents | 1 | 2018 | 1510 | 0.020 |
Why?
| Hospitals, University | 1 | 2008 | 172 | 0.020 |
Why?
| Natriuresis | 1 | 2007 | 14 | 0.020 |
Why?
| Patient Participation | 1 | 2010 | 369 | 0.020 |
Why?
| Kidney Function Tests | 1 | 2007 | 164 | 0.020 |
Why?
| Ontario | 1 | 2006 | 111 | 0.020 |
Why?
| Risk | 1 | 2009 | 853 | 0.020 |
Why?
| Pravastatin | 1 | 2006 | 29 | 0.020 |
Why?
| Lovastatin | 1 | 2006 | 27 | 0.020 |
Why?
| Fatty Acids, Monounsaturated | 1 | 2006 | 46 | 0.020 |
Why?
| Heptanoic Acids | 1 | 2006 | 62 | 0.020 |
Why?
| Sleep Wake Disorders | 1 | 2009 | 241 | 0.020 |
Why?
| Databases as Topic | 1 | 2005 | 73 | 0.020 |
Why?
| Hematocrit | 1 | 2005 | 91 | 0.020 |
Why?
| Family | 1 | 2009 | 585 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2007 | 736 | 0.020 |
Why?
| Hospitals, Teaching | 1 | 2005 | 104 | 0.020 |
Why?
| Midwestern United States | 1 | 2004 | 38 | 0.020 |
Why?
| Hospitals, Urban | 1 | 2005 | 129 | 0.020 |
Why?
| Northwestern United States | 1 | 2004 | 56 | 0.020 |
Why?
| Cognition Disorders | 1 | 2009 | 529 | 0.020 |
Why?
| Pyrroles | 1 | 2006 | 191 | 0.020 |
Why?
| Potassium | 1 | 2005 | 132 | 0.020 |
Why?
| Hospitals, Municipal | 1 | 2004 | 2 | 0.020 |
Why?
| Age Distribution | 1 | 2005 | 362 | 0.020 |
Why?
| Myocardial Revascularization | 1 | 2004 | 72 | 0.020 |
Why?
| Cognition | 1 | 2012 | 1024 | 0.020 |
Why?
| Disease-Free Survival | 1 | 2006 | 649 | 0.020 |
Why?
| Indoles | 1 | 2006 | 316 | 0.010 |
Why?
| Anti-Arrhythmia Agents | 1 | 2004 | 113 | 0.010 |
Why?
| Drug Utilization | 1 | 2004 | 169 | 0.010 |
Why?
| Smoking | 1 | 2011 | 1487 | 0.010 |
Why?
| Drug Utilization Review | 1 | 2003 | 60 | 0.010 |
Why?
| Fee-for-Service Plans | 1 | 2003 | 79 | 0.010 |
Why?
| Arrhythmias, Cardiac | 1 | 2005 | 277 | 0.010 |
Why?
| Cardiotonic Agents | 1 | 2003 | 127 | 0.010 |
Why?
| Overweight | 1 | 2006 | 502 | 0.010 |
Why?
| Drug Interactions | 1 | 2003 | 352 | 0.010 |
Why?
| Pyridines | 1 | 2006 | 440 | 0.010 |
Why?
| Electrolytes | 1 | 2002 | 59 | 0.010 |
Why?
| Urinalysis | 1 | 2002 | 68 | 0.010 |
Why?
| Drug Combinations | 1 | 2002 | 291 | 0.010 |
Why?
| Sodium | 1 | 2002 | 200 | 0.010 |
Why?
| Morbidity | 1 | 2002 | 296 | 0.010 |
Why?
| Cardiac Catheterization | 1 | 2004 | 541 | 0.010 |
Why?
| Drug Therapy, Combination | 1 | 2003 | 965 | 0.010 |
Why?
| Referral and Consultation | 1 | 2005 | 648 | 0.010 |
Why?
| Diabetic Nephropathies | 1 | 2004 | 289 | 0.010 |
Why?
| Cross-Over Studies | 1 | 2002 | 456 | 0.010 |
Why?
| Mental Disorders | 1 | 2008 | 939 | 0.010 |
Why?
| Heart Ventricles | 1 | 2005 | 727 | 0.010 |
Why?
| Recovery of Function | 1 | 2003 | 604 | 0.010 |
Why?
| Substance-Related Disorders | 1 | 2008 | 971 | 0.010 |
Why?
| Case-Control Studies | 1 | 2005 | 3171 | 0.010 |
Why?
| Hemodynamics | 1 | 2002 | 1003 | 0.010 |
Why?
| Internship and Residency | 1 | 2004 | 1001 | 0.010 |
Why?
|
|
Havranek's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|